Q3 FY26 results: revenue up, but net loss of Rs 26 lakh in quarter

Net loss reportedExceptional itemResults View source PDF Explain this filing

LOTUSEYE · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

-2.6%Reaction day

₹122.15

prior close

₹122.10

announcement price

After-mkt

timing

Nifty Microcap 250market · in no size index; the smallest one is used-0.5%-2.1% vs market

Hospital peers, median of 23sector+0.5%-3.1% vs sector

On the reaction day the stock moved 2.1 pts less than Nifty Microcap 250 and 3.1 pts less than its Hospital peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

-0.5

10m

-0.1

15m

-0.5

30m

-0.2

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

-2.6-0.5-2.1+0.5-3.1

Next day

-7.5-2.0-5.6-0.9-6.7

-2.8-2.7-0.1-0.5-2.3

+1.8-1.7+3.5+0.9+0.9

+6.6-1.4+8.0+0.5+6.1

+1.3-2.8+4.1-0.7+2.0

-8.6-2.8-5.8+0.3-8.9

15d

-9.3-8.4-0.9-3.5-5.8

-14.1-9.1-5.0-4.3-9.9

-12.2-4.0-8.1-3.7-8.5

-5.9+2.6-8.5+4.0-9.8

UpDownMarket · Nifty Microcap 250Sector · Hospital peers, median of 23Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Lotus Eye Hospital reported Q3 FY26 revenue of Rs 1,354.96 lakhs, up 10.6 percent YoY. Despite revenue growth, the company posted a net loss of Rs 26.07 lakhs in the quarter versus a loss of Rs 23.91 lakhs in Q3 FY25. For nine months, revenue grew 5.4 percent to Rs 4,010.49 lakhs while net profit fell to Rs 39.99 lakhs from Rs 48.69 lakhs. Total expenses in Q3 rose to Rs 1,416.07 lakhs. Limited review by Anbarasu and Jalapathi was clean. Board also appointed Mr. Prathish S as Company Secretary effective Feb 13, 2026.

Likely market impact

Mixed results: revenue growth positive but profitability under pressure with a quarterly loss; margins remain thin and cost growth outpaces revenue.